PHOENIX, Nov. 05, 2018 (GLOBE NEWSWIRE) -- Dennis Calvert, CEO of BioLargo, Inc. (OTCQB:BLGO), recently spoke with Stock Day Podcast’s Everett Jolly to update listeners on the
company’s recent milestones.
Jolly started out the interview highlighting that BioLargo’s odor and VOC control products are set to do over $1 million in
revenue in 2018.
“We launched the product about two years ago into the municipal waste handling industry,” Calvert explains to Uptick. “It took
us about a year to get our foothold in the market and over the past six months, we signed national purchasing agreements with four
of the top municipal waste handling companies in the country and have enjoyed 100% regional adoption with those accounts in
Southern California, so the market is finally catching on that ours is a great product backed by great service. We are also
servicing early adopters in the waste water treatment industry and new industries are just getting started as well. We have also
transitioned from being a tech shop to a solutions provider, adding engineering, system design, installation, maintenance and
service. We have only scratched the surface of the global opportunity for CupriDyne Clean.”
Jolly then shifted the interview to talk about Clyra Medical Technologies, Inc., the BioLargo subsidiary that uses innovative
patent protected chemistry in advanced wound care. Calvert discussed the progress of its advanced wound care products under its
subsidiary Clyra Medical Technologies, and its recent 510 (k) application with the FDA.
In a follow-up to the interview, Calvert expanded on their recent trip to Washington, DC to meet with the FDA about the
company’s pending application. “In our meeting with FDA representatives last week, we were able to clarify the data requirements
and the appropriate pathway to success for our application. The first series of questions asked of our team relates to labeling,
shelf-life, and composition, and we think that request and the answers are straight forward. The more important request they made
was that we conduct a short-term live animal study which requires a small period of work and money to accomplish. We believe the
time frame to meet these requests is manageable within the next few months, and that the outcome will ultimately result in FDA
clearance of the product.”
Jolly also asked Dennis about BioLargo Water’s AOS (Advanced Oxidation System), which is a technological breakthrough in water
and wastewater treatment and has the potential to provide effective and cost-efficient elimination of pathogens and hard-to-treat
organics from wastewater. Calvert said the product is nearing commercialization and is even currently part of several
pre-commercial pilot projects in real world industrial settings. He also went on to explain the exciting independent
3rd-party validation of the high-value use of the AOS for managing micropollutants and other hard-to-treat contaminants
for the wastewater industry.
“We have major projects that all focus on taking the system into the field to work with real clients to prove out its real
economic value,” Calvert explained. “It’s the final piece of making that technology ready for market. We think it’s pretty
exciting.”
To hear the entire interview with Dennis Calvert, click the Stock Day podcast link (https://upticknewswire.com/featured-interview-ceo-dennis-calvert-of-biolargo-inc-otcqb-blgo-10/).
About BioLargo, Inc.
BioLargo, Inc. is an innovative technology developer and environmental engineering company driven by a mission to "make life
better" by delivering robust, sustainable solutions for a broad range of industries and applications, with a focus on clean water,
clean air, and advanced wound care. We develop and commercialize disruptive technologies by providing the capital, support, and
expertise to expedite them from "cradle" to "maturity" (www.biolargo.com). Our engineering division features experienced
professional engineers dedicated to integrity, reliability, and environmental stewardship (www.biolargoengineering.com). Our
industrial odor control division, Odor-No-More (www.odornomore.com) features CupriDyne Clean Industrial Odor Eliminator
(www.cupridyne.com), which eliminates the odor-causing compounds and VOCs rather than masking them, and is now winning over leading
companies in the solid waste handling and wastewater industries and other industries that contend with malodors and VOCs. Our
subsidiary BioLargo Water (www.biolargowater.ca) develops the Advanced Oxidation System "AOS," a disruptive industrial water
treatment technology designed to eliminate waterborne pathogens and recalcitrant contaminants with better energy-efficiency and
lower operational costs than incumbent technologies. Our subsidiary Clyra Medical (www.clyramedical.com) features effective and
gentle solutions for chronic infected wounds to promote infection control and regenerative tissue therapy.
Contact Information:
Dennis Calvert President and CEO BioLargo, Inc. 949-643-9540 x2
Safe Harbor Act
This press release includes “forward-looking statements” within the meaning of the safe harbor provisions of the United States
Private Securities Litigation Reform Act of 1995. Actual results may differ from expectations, estimates and projections and,
consequently, you should not rely on these forward-looking statements as predictions of future events. Words such as “expect,”
“estimate,” “project,” “budget,” “forecast,” “anticipate,” “intend,” “plan,” “may,” “will,” “could,” “should,” “believes,”
“predicts,” “potential,” “continue,” and similar expressions are intended to identify such forward-looking statements. These
forward-looking statements involve significant risks and uncertainties that could cause the actual results to differ materially
from the expected results.
About Uptick Newswire and the “Stock Day” Podcast
Founded in 2013, Uptick Newswire is the fastest growing media outlet for Nano-Cap and Micro-Cap companies. It educates investors
while simultaneously working with penny stock and OTC companies, providing transparency and clarification of under-valued,
under-sold Micro-Cap stocks of the market. Uptick provides companies with customized solutions to their news distribution in both
national and international media outlets. Uptick is the sole producer of its “Stock Day” Podcast, which is the number one radio
show of its kind in America. The Uptick Network “Stock Day” Podcast is an extension of Uptick Newswire, which recently launched its
Video Interview Studio located in Phoenix, Arizona.
Investors Hangout is a proud sponsor of “Stock Day,” and Uptick Newswire encourages listeners to visit the
company’s message board at https://investorshangout.com/
SOURCE:
Uptick Newswire
https://upticknewswire.com/
